WHO ICTRP trial
Lipids in Diabetes Study
ISRCTN22144829 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN22144829 |
|---|---|
| Public title | Lipids in Diabetes Study |
| Primary sponsor | Bayer PLC (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Type 2 diabetes Nutritional, Metabolic, Endocrine Diabetes |
| Interventions | 1. Cerivastatin and placebo 2. Fenofibrate and placebo 3. Cerivastatin and fenofibrate 4. Placebo |
| Registration date | May 31, 2002 |
| Target size | 5000 |
| Secondary IDs | BAY w 6228/200016 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: